Valion Bio

VBIONasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$3.201 M

$2.49 +4.62%

Close of 22 Sept 2026

Revenue

$780.0K

#3501 by revenue

Earnings

-$8.88M

Loss-making

Shares outstanding

22,189,739

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#24IridexIRIX$11.2M
#25ENDRA Life SciencesNDRA$9.34M
#26Nexalin TechnologyNXL$3.84M
#27Valion BioVBIO$3.20M
#28NuwellisNUWE$3.01M

What if Valion Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$23,516,945

Per share 9,444,556× higher

Bitcoin $1.74T

$1,354,715

Per share 544,062× higher

Nvidia $5.52T

$4,290,339

Per share 1,723,028× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Valion Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.